UnknownPhase 2/3

Misoprostol for Cervical Priming Before Office Hysteroscopy

Egypt100 participantsStarted 2017-10-01

Plain-language summary

The objective of the present study is to evaluate the appropriate route of administration of misoprostol, either oral or vaginal, for cervical priming to facilitate the procedure of office hysteroscopy and reduce patient discomfort to minimum

Who can participate

Age range19 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients indicated for diagnostic hysteroscopy for infertility or AUB.
✓. Reproductive age \>19 - 45yrs.
✓. Postmenstrual between days 7 and 11 of the cycle ( except in irregular bleeding)

Exclusion criteria

✕. Cardiovascular disease
✕. Severe bronchial asthma.
✕. Hypertension.
✕. Renal failure.
✕. Known sensitivity to Prostaglandins
✕. Pelvic inflammatory disease.
✕. Marked cervical stenosis.
✕. Known cervical malignancy.

What they're measuring

Pain sensation:

Timeframe: The VAS will be applied immediately after the procedure ended.

Patient acceptability

Timeframe: The VAS will be applied immediately after the procedure ended.

Trial details

NCT IDNCT03276000

SponsorKasr El Aini Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03-01

Contact for this trial

Sarah M Hassan, lecturer

01003733671 saramohamed7880@yahoo.com

View on ClinicalTrials.gov More Misoprostol Allergy trials